The Recurring Prescription: What UK Cannabis Patients Are Actually Signing Up For

There's a certain rhythm to private healthcare in Britain now. You don't ring a clinic, wait three weeks and turn up in person. You fill in a form at 11pm, get a video call within days, and then — if all goes to plan — a box arrives. And then another box. And then another. Somewhere along the way, the appointment became a subscription.

Medical cannabis in the UK has matured into something that looks less like a specialist consultation and more like a monthly service plan. You've got tiers, bundled reviews, "membership" language borrowed from gyms and streaming platforms, and a direct debit that ticks over long after the initial conversation about your symptoms. For some patients, that predictability is genuinely useful. For others, it's a slow drift into paying for continuity they didn't exactly choose.

How the monthly model actually works

Almost nobody advertises a flat fee for cannabis. What they advertise is access. A typical private clinic might charge somewhere between £15 and £40 a month as a membership or "care plan" fee, on top of a consultation charge at the start and periodic follow-up reviews — usually every three to six months, sometimes more often if your dose is being adjusted. Then there's the prescription itself, which is dispensed by a pharmacy, often one partnered with or owned by the same group.

Add it up and the cost of staying legal as a UK patient can comfortably sit in the low hundreds per month depending on what's prescribed, before you've factored in repeat prescription charges, delivery fees or the occasional administrative charge for a letter your employer or university has asked for. None of this is hidden in the way a scam would hide it. It's just spread across enough small line items that the total never appears in one place.

That's the first thing worth understanding: the subscription isn't really the medicine. It's the paperwork, the review, the ongoing permission to keep being prescribed. You're paying for continuity of access, not for the product itself.

The lock-in that doesn't look like lock-in

Here's where it gets interesting, and where patients tend to have opinions. Under UK rules, a prescription for a controlled drug isn't a repeat in the way your GP's blood pressure script is. It has to be issued by a prescriber, and clinics build their business around being that prescriber on an ongoing basis. Some patients report being told they need a review before each repeat, which conveniently lines up with the monthly fee.

Others have found that switching clinics mid-treatment isn't quite the clean break it sounds. You may need a new initial consultation elsewhere — full price, not the cheaper follow-up rate — and a fresh assessment, because the new clinic can't simply inherit someone else's clinical judgement. That's not unreasonable from a safety perspective. But it does mean the cost of leaving is front-loaded, and a patient who's happy enough but not thrilled has a real financial reason to stay put.

Then there's the pharmacy question. If your clinic steers you to a partner pharmacy, you may not have shopped around for the same product elsewhere. Some patients have found that requesting a paper copy of their script to take to an independent pharmacy is met with a bit of friction — a delay here, a query there. Nothing illegal, nothing dramatic, just enough inconvenience that most people shrug and stick with the default.

What patients say they're paying for

The honest answer, from the patients I've spoken to, is that they're paying for speed and for not being made to feel like a criminal. The private route is expensive because it's fast, and because it exists in the gap left by an NHS that still won't routinely prescribe cannabis for most conditions. People aren't naive about this. They know the monthly fee is a business model.

The frustration tends to arrive later, when the service feels thinner than the price suggests. A five-minute video review that costs £45. A portal that doesn't quite work. A dispensary that runs out of the strain that finally helped. A clinic that's brilliant at onboarding and slightly less brilliant at answering an email in month nine. Those are the moments when the subscription framing starts to feel less like care and more like a contract you're locked into by inertia.

Where the model goes next

There are signs of movement. More clinics are publishing transparent price lists, some are offering annual plans with a discount, and a handful are experimenting with reduced fees for patients on lower incomes or with concessionary status. Competition is doing what competition does, slowly, unevenly, and mostly in the cities where patients already have options.

The question worth asking isn't whether subscriptions are good or bad. It's whether patients can see, clearly and in one place, what they're committing to each month and what it would cost to walk away. That's not an unreasonable standard for a gym, and it shouldn't be an unreasonable one for your medicine. Read the plan before you sign it. Ask what happens if you want to leave. Ask for the script in writing. The direct debit is easy to set up — it's the untangling that takes the effort.